Concepedia
Statistics
Publications
17
Citations
2.4K
H-Index
14
Active since
2011
Affiliations
Eli Lilly (United States)(Current)
Pennsylvania State University
Air Vehicle Integrated Design (United States)
Butler Hospital
University of Pennsylvania
Michael Navitsky is an author at Eli Lilly (United States) specializing in medicine, alzheimer disease, and dementia.
Publications per year
2011–2023
Positron Emission Tomography Imaging With [<sup>18</sup>F]flortaucipir and Postmortem Assessment of Alzheimer Disease Neuropathologic Changes
Adam Fleisher, Michael J. Pontecorvo, Michael D. Devous et al. · JAMA Neurology · 2020 · 443 citations · Full text
Medicine, Nuclear Medicine, Radiology +17
Regional profiles of the candidate tau PET ligand <sup>18</sup> F-AV-1451 recapitulate key features of Braak histopathological stages
Adam J. Schwarz, Peng Yu, Bradley B. Miller et al. · Brain · 2016 · 431 citations · Full text
Medicine, Neurology, Neuroscience +17
Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition
Michael J. Pontecorvo, Michael D. Devous, Michael Navitsky et al. · Brain · 2017 · 362 citations · Full text
Medicine, Neurology, Nuclear Medicine +17
A multicentre longitudinal study of flortaucipir (18F) in normal ageing, mild cognitive impairment and Alzheimer’s disease dementia
Michael J. Pontecorvo, Michael D. Devous, Ian Kennedy et al. · Brain · 2019 · 254 citations · Full text
Standardization of amyloid quantitation with florbetapir standardized uptake value ratios to the Centiloid scale
Michael Navitsky, Abhinay D. Joshi, Ian Kennedy et al. · Alzheimer s & Dementia · 2018 · 223 citations
Pharmacy, Translational Sciences, Analytical Chemistry +7
1–5 of 17